Riskpilot← Back to searchSign inGet full accessAxelot AB
ABActiveOrg 5568809023Enebergsgatan 6Medical specialists activities · NACE 8622Est. 20120 employees
Revenue 2025
SEK 8K
-37% vs 2024
EBITDA margin
-907.5%
+58% vs 2024
Equity ratio
99.1%
Financial strength
Net profit 2025
SEK -64K
-61% vs 2024
| Revenue | SEK 8K | -37% |
| EBITDA | SEK -75K | +58% |
| Net profit | SEK -64K | -61% |
| Total assets | SEK 921K | -23% |
| Equity | SEK 913K | -23% |
| Employees | 0 | — |
Legal name
Axelot AB
Org number
5568809023
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
16 januari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva medicinsk, paramedicinsk psykoterapeutisk behandling, forskning och utveckling samt produktion, import och försäljning av livsmedel, hälsoprodukter samt därmed förenlig verksamhet.
Address
Enebergsgatan 6
Email
kristina.widmark@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 200 | 221 | 7 | 13 | 8 |
| Staff expenses | — | −64 | −308 | −39 | −15 |
| EBITDA | 707 | 53 | −366 | −178 | −75 |
| Depreciation & amort. | −29 | −29 | −29 | −29 | — |
| EBIT | 678 | 24 | −394 | −207 | −75 |
| Net financials | — | 4 | 31 | 23 | 11 |
| Profit before tax | 867 | 25 | −29 | −39 | −64 |
| Tax | −183 | −7 | — | — | — |
| Net profit | 684 | 17 | −29 | −39 | −64 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 548 | 2 149 | 1 585 | 1 201 | 921 |
| Equity | 1 825 | 1 655 | 1 426 | 1 187 | 913 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 248 | 16 | 14 | 14 | 8 |
| Total debt | 248 | 16 | 14 | 14 | 8 |
EBITDA margin
-907.5%
This company
15.8%
Market median
-5844% vs market
20212025
Equity ratio
99.1%
This company
38.2%
Market median
+159% vs market
20212025
Return on equity
-7.0%
This company
18.4%
Market median
-138% vs market
20212025
Net profit margin
-770.1%
This company
8.1%
Market median
-9607% vs market
20212025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Axelot AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Carl Wilhelm Widmark | Deputy Board Member | 0 companies |
| Kristina Elisabeth Widmark | Board of Directors | 0 companies |